At present, individualized vaccine design based on tumor-specific antigens is an increasing trend.
← all excerpts
The advantages of NK cell vaccines in solid carcinoma clinical trials: conducted by various biology strategy and technology.
1
—
—
At present, individualized vaccine design based on tumor-specific antigens is an increasing trend.